Seeking Alpha

Advaxis jumps after FDA grants orphan drug designation for ADXS-HPV

  • Advaxis (ADXS +5.7%) shares jump after the FDA grants the company an orphan drug designation for its leading drug candidate, ADXS-HPV, which aims to treat HPV-caused head/neck cancer.
Comments (3)
  • Awesome news! This company has a bright future.
    4 Nov 2013, 12:22 PM Reply Like
  • Is there a price target?
    5 Nov 2013, 04:38 AM Reply Like
  • What happened to it today (11/11)?
    11 Nov 2013, 02:46 PM Reply Like
DJIA (DIA) S&P 500 (SPY)